Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SRD5A1 ELISA Kit (AC3788)
Cat.#: ASET-2377
Specifications
Description Human SRD5A1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SRD5A1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.029 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1392 Human Semaphorin 3A ELISA Kit (AC2803) Quantitative inquiry ASET-2060 Porcine GDNF ELISA Kit (AC3471) Quantitative inquiry ASET-1230 Mouse DLK-1 ELISA Kit (AC2641) Quantitative inquiry ASET-1469 Mouse Choline Acetyltransferase ELISA Kit (AC2880) Quantitative inquiry ASET-2461 Human GRIP1 ELISA Kit (AC3872) Quantitative inquiry ASET-1365 Rat Progranulin ELISA Kit (AC2776) Quantitative inquiry ASET-1025 Human PINK1 ELISA Kit (AC2436) Quantitative inquiry ASET-2275 Human Calbindin ELISA Kit (AC3686) Quantitative inquiry ASET-1289 Human Semaphorin 3E ELISA Kit (AC2700) Quantitative inquiry ASET-2494 Rat Inhibin beta B ELISA Kit (AC3905) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket